Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Genetic polymorphisms of drug metabolism.

Progress in liver diseases - 1 Jan 1990

Meyer U A, Zanger U M, Skoda R C, Grant D, Blum M

Abstract excerpt

No abstract is available from the source.

Topics

Arylamine N-Acetyltransferase
Cytochrome P-450 Enzyme System
Debrisoquin
Humans
Liver
Mephenytoin
Mutation
Pharmaceutical Preparations
Polymorphism, Genetic
Sparteine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 2156298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of drug metabolism.PMID 2156298Read ↗

The clinical role of genetic polymorphisms in drug-metabolizing enzymesSemantic proximity Read ↗

Genetic factors in drug metabolism.Semantic proximity Read ↗

Pharmacogenetics and drug metabolism.Semantic proximity Read ↗

[Genetic polymorphism of drug metabolizing enzymes].Semantic proximity Read ↗

The impact of genetic polymorphisms in risk assessment of drugs.Semantic proximity Read ↗

[Clinical relevance of drug metabolism polymorphisms].Semantic proximity Read ↗

[Polymorphism of enzymes involved in drug metabolism: gene structure and enzymatic activity].Semantic proximity Read ↗

Hereditary polymorphisms of human drug metabolizing enzymes and cancer susceptibility.Semantic proximity Read ↗

Genetic aspects of drug disposition and therapeutics.Semantic proximity Read ↗

Genetically determined polymorphisms in drug oxidation.Semantic proximity Read ↗

Clinically relevant genetic variations in drug metabolizing enzymes.Semantic proximity Read ↗

Identification of genetic differences in drug metabolism: prediction of individual risk of toxicity or cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.